查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1964006

医药协作机器人市场－全球产业规模、份额、趋势、机会、预测：按应用、最终用途、地区和竞争格局划分，2021-2031年

Pharmaceutical Collaborative Robots Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球医药协作机器人市场预计将从 2025 年的 7,912 万美元成长到 2031 年的 1.3445 亿美元，复合年增长率为 9.24%。

这些协作机器人是专门设计的自动化系统，旨在与人类工人在共用环境中安全协作，并越来越多地承担诸如无菌配製、包装和实验室分析等任务。推动这一成长的因素包括：在高精度环境中减少人为错误、满足对无污染生产区域的需求以及解决技术纯熟劳工短缺问题。除了这些技术趋势之外，营运因素也反映了该行业对效率和安全性的需求。例如，国际机器人联合会 (IFR) 报告称，到 2024 年，诊断和医疗检测机器人的销售将增加 610%，这反映了对自动化的依赖。

市场概览
预测期 2027-2031
市场规模：2025年 7912万美元
市场规模：2031年 1.3445亿美元
复合年增长率：2026-2031年 9.24%
成长最快的细分市场 拣货和包装
最大的市场 北美洲

儘管存在这些成长要素，但监管製药生产的严格合规环境对市场扩张构成了重大障碍。全球卫生监管机构强制执行严格的药品生产品质管理通讯协定(GMP)，要求对新引入的自动化设备进行大量的文件记录和测试。这种复杂的检验流程通常会导致更长的部署週期和更高的实施成本，对那些希望将这些协作系统整合到检验的工作流程中的公司而言，构成了一项重大挑战。

市场驱动因素

对营运效率和高通量自动化的需求是推动市场成长的主要动力，製药公司正积极采用协作机器人来简化复杂的生产流程，例如细胞疗法生产。这种转变不仅限于速度提升，更着眼于在个人化医疗生产中实现显着的成本降低。例如，Universal Robots 于 2025 年 8 月发布的一份题为《机器人技术变革细胞疗法》的案例研究指出，引入用于生物製造的新型机器人丛集，与人工操作相比，可使运营成本降低 74%，并大幅提高产能。

此外，为最大限度减少关键操作和品管环节中的人为错误，协作机器人的应用正在加速普及。在监管严格的製药行业，保持无菌和零缺陷生产至关重要，而协作机器人能够以极高的精度执行重复性、高精度任务，从而满足这些需求。这种能力对于降低污染风险和提高产品安全性至关重要。如同2025年2月发表于《机器人未来》（RoboticsTomorrow）杂誌的报导《製药机器人的崛起》所述，将自动化引入製药生产可以将产品瑕疵减少高达80%。为了反映这一发展势头，自动化协会（AAA）指出，2025年第二季生命科学和製药业的机器人订单增了22%。

市场挑战

製药业严格的监管环境是协作机器人市场成长的主要阻碍因素。这些自动化系统必须符合严格的药品生产品质管理规范 (GMP)，因为它们直接接触敏感的药品和关键的生产流程。这项要求需要完善的检验通讯协定，包括安装资格确认(IQ)、运作资格确认(OQ) 和效能资格确认(PQ)，以彻底消除错误和污染的风险。这种全面的文件记录和测试要求显着增加了实施成本，并延长了新设备的部署时间。这往往会延迟投资回报，并阻碍协作系统的快速部署。

鑑于该行业对自动化日益增长的需求，这项监管瓶颈尤为重要。根据自动化促进协会（Association for Advancing Automation）的数据显示，2024年生命科学、製药和生物医学产业的机器人订单激增46%。儘管采购量的成长显示了对自动化应用的坚定承诺，但复杂且往往延误的核准流程限制了这些资产运作，从而减缓了市场的实际成长速度。

市场趋势

在细胞疗法和基因疗法等先进治疗药物（ATMP）的快速发展推动下，小批量个人化医疗的自动化配药正成为一种变革性趋势。与传统的大规模生产不同，这些治疗方法需要在严格的无菌条件下处理患者特异性生物材料。协作机器人在这方面表现出色，它们在隔离屏障系统内运行，并且能够比人工操作更稳定地进行精细的液体处理，从而确保无菌并维护身份链。安川电机株式会社与Astellas製药于2024年5月签署的伙伴关係谅解备忘录，清楚体现了对自动化个人化医疗的重视。该备忘录旨在共同开发一个整合机器人技术的细胞治疗生态系统，以实现高精度流程的标准化。

同时，製药业正朝着模组化和可重构的生产单元方向发展，尤其是在包装和套件组装流程中。製药公司正在加速用灵活的协作机器人单元取代僵化的、单一用途的自动化生产线，这些协作机器人单元能够快速响应频繁的产品切换和多样​​化的包装形式。这种模组化设计能够有效管理多品种、小批量生产，随着产品生命週期缩短和SKU复杂性增加，这一点变得愈发重要。美国自动化协会 (AAA) 最新发布的《2025年第一季北美机器人订单趋势》报告的数据也反映了对这些高度适应性解决方案的需求。报告显示，光是2025年第一季，生命科学、製药和生物医学领域就订单了127台协作机器人。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：製药业协作机器人的全球市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 按应用领域（拣货和包装、药物测试、实验室用途）
    • 依最终用户（製药公司、研究机构等）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美製药业协作机器人市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲製药业协作机器人市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区製药协作机器人市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲製药产业协作机器人市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲製药协作机器人市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章 全球製药协作机器人市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • ABB Ltd
  • Universal Robots A/S
  • Mitsubishi Electric Corporation
  • KUKA AG
  • Kawasaki Heavy Industries Ltd
  • Yaskawa Electric Corporation
  • DENSO Wave Inc
  • FANUC Corporation
  • Omron Corporation
  • Seiko Epson Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 21982

The Global Pharmaceutical Collaborative Robots Market is projected to expand from USD 79.12 Million in 2025 to USD 134.45 Million by 2031, registering a CAGR of 9.24%. These collaborative robots are specialized automated systems engineered to function safely alongside human workers in shared environments, increasingly handling tasks such as sterile compounding, packaging, and laboratory analysis. Growth is fundamentally supported by the urgent need to reduce human error in high-precision settings, the demand for contamination-free manufacturing areas, and the necessity to offset skilled labor shortages. These operational drivers, distinct from purely technological trends, emphasize the industry's need for efficiency and safety. Illustrating this reliance on automation, the International Federation of Robotics reported a 610% increase in sales of robots for diagnostics and medical laboratory analysis in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 79.12 Million
Market Size 2031USD 134.45 Million
CAGR 2026-20319.24%
Fastest Growing SegmentPicking and Packaging
Largest MarketNorth America

Despite these drivers, the rigorous regulatory compliance landscape governing pharmaceutical production poses a significant obstacle to broader market expansion. Global health authorities enforce stringent Good Manufacturing Practice protocols, which mandate extensive documentation and testing for any new automated machinery. This complex validation process frequently leads to prolonged deployment timelines and escalated implementation costs, presenting a substantial barrier for companies seeking to incorporate these collaborative systems into validated workflows.

Market Driver

The necessity for operational efficiency and high-throughput automation serves as a primary engine for market growth, prompting pharmaceutical manufacturers to aggressively adopt collaborative robots for streamlining complex workflows like cell therapy production. This transition moves beyond mere speed, focusing on achieving significant cost reductions in personalized medicine manufacturing. For instance, a case study titled 'Robotics transforms cell therapy' by Universal Robots in August 2025 highlighted that deploying a new robotic cluster for biomanufacturing resulted in a 74% decrease in operational costs while substantially boosting production capacity compared to manual techniques.

Additionally, the drive to minimize human error in critical handling and quality control tasks fuels widespread adoption. In the highly regulated pharmaceutical industry, maintaining sterile conditions and ensuring zero-defect outputs are essential, and cobots address these needs by executing repetitive, high-precision tasks with unwavering accuracy. This capability is vital for mitigating contamination risks and improving product safety. As reported by RoboticsTomorrow in the February 2025 article 'The Rise of Pharma Robots,' integrating automation in drug manufacturing can reduce product defects by up to 80%. Mirroring this momentum, the Association for Advancing Automation noted a 22% increase in robot orders from the life sciences and pharmaceutical sector during the second quarter of 2025 compared to the prior year.

Market Challenge

The strict regulatory compliance landscape within pharmaceutical production serves as a major restraint on the collaborative robots market's growth. Since these automated systems interact directly with sensitive drug products and essential manufacturing processes, they must adhere to rigorous Good Manufacturing Practice standards. This requirement necessitates exhaustive validation protocols, including Installation, Operational, and Performance Qualifications, to guarantee zero risk of error or contamination. The need for such comprehensive documentation and testing considerably increases implementation costs and prolongs the time required to deploy new machinery, often delaying returns on investment and discouraging the rapid integration of collaborative systems.

This regulatory bottleneck is especially significant given the rising demand for automation in the sector. According to the Association for Advancing Automation, robot orders from the life sciences, pharmaceutical, and biomedical industries surged by 46% in 2024. Although this increase in procurement demonstrates a strong intent to adopt automation, the complex and slow approval framework limits the pace at which these assets can be brought online, effectively slowing the market's realized growth rate.

Market Trends

The deployment of automation in small-batch personalized medicine compounding is emerging as a transformative trend, fueled by the growth of Advanced Therapy Medicinal Products such as cell and gene therapies. Unlike traditional bulk manufacturing, these treatments demand the handling of patient-specific biological materials under strictly aseptic conditions. Collaborative robots are uniquely capable in this area, operating within isolated barrier systems to execute delicate liquid handling with greater consistency than human operators, thereby ensuring sterility and maintaining the chain of identity. This focus on automated personalized care is highlighted by Yaskawa Electric Corporation's May 2024 announcement regarding the 'Astellas Pharma Partnership,' where a memorandum of understanding was signed to co-develop a cell therapy ecosystem integrating robotics to standardize high-precision processes.

Simultaneously, the industry is shifting towards modular and reconfigurable manufacturing cells, particularly for packaging and kitting operations. Pharmaceutical manufacturers are increasingly replacing rigid, single-purpose automation lines with flexible cobot cells capable of adapting quickly to frequent product changeovers and diverse packaging formats. This modularity enables facilities to efficiently manage high-mix, low-volume production runs, which is critical as product lifecycles shorten and SKU complexity rises. The demand for such adaptable solutions is reflected in recent data from the Association for Advancing Automation's 'Q1 2025 North American Robot Orders' report, which noted that the Life Sciences, Pharmaceutical, and Biomedical sector ordered 127 collaborative robot units in the first quarter of 2025 alone.

Key Market Players

  • ABB Ltd
  • Universal Robots A/S
  • Mitsubishi Electric Corporation
  • KUKA AG
  • Kawasaki Heavy Industries Ltd
  • Yaskawa Electric Corporation
  • DENSO Wave Inc
  • FANUC Corporation
  • Omron Corporation
  • Seiko Epson Corporation

Report Scope

In this report, the Global Pharmaceutical Collaborative Robots Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Collaborative Robots Market, By Application

  • Picking and Packaging
  • Inspection of Pharmaceutical Drugs
  • Laboratory Applications

Pharmaceutical Collaborative Robots Market, By End-use

  • Pharmaceutical Companies
  • Research Laboratories
  • Others

Pharmaceutical Collaborative Robots Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Collaborative Robots Market.

Available Customizations:

Global Pharmaceutical Collaborative Robots Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmaceutical Collaborative Robots Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Picking and Packaging, Inspection of Pharmaceutical Drugs, Laboratory Applications)
    • 5.2.2. By End-use (Pharmaceutical Companies, Research Laboratories, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Pharmaceutical Collaborative Robots Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application
    • 6.2.2. By End-use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Pharmaceutical Collaborative Robots Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By End-use
    • 6.3.2. Canada Pharmaceutical Collaborative Robots Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By End-use
    • 6.3.3. Mexico Pharmaceutical Collaborative Robots Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By End-use

7. Europe Pharmaceutical Collaborative Robots Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application
    • 7.2.2. By End-use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Pharmaceutical Collaborative Robots Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By End-use
    • 7.3.2. France Pharmaceutical Collaborative Robots Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By End-use
    • 7.3.3. United Kingdom Pharmaceutical Collaborative Robots Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By End-use
    • 7.3.4. Italy Pharmaceutical Collaborative Robots Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By End-use
    • 7.3.5. Spain Pharmaceutical Collaborative Robots Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By End-use

8. Asia Pacific Pharmaceutical Collaborative Robots Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application
    • 8.2.2. By End-use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Pharmaceutical Collaborative Robots Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By End-use
    • 8.3.2. India Pharmaceutical Collaborative Robots Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By End-use
    • 8.3.3. Japan Pharmaceutical Collaborative Robots Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By End-use
    • 8.3.4. South Korea Pharmaceutical Collaborative Robots Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By End-use
    • 8.3.5. Australia Pharmaceutical Collaborative Robots Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By End-use

9. Middle East & Africa Pharmaceutical Collaborative Robots Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application
    • 9.2.2. By End-use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Pharmaceutical Collaborative Robots Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By End-use
    • 9.3.2. UAE Pharmaceutical Collaborative Robots Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By End-use
    • 9.3.3. South Africa Pharmaceutical Collaborative Robots Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By End-use

10. South America Pharmaceutical Collaborative Robots Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application
    • 10.2.2. By End-use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Pharmaceutical Collaborative Robots Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By End-use
    • 10.3.2. Colombia Pharmaceutical Collaborative Robots Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By End-use
    • 10.3.3. Argentina Pharmaceutical Collaborative Robots Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Pharmaceutical Collaborative Robots Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. ABB Ltd
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Universal Robots A/S
  • 15.3. Mitsubishi Electric Corporation
  • 15.4. KUKA AG
  • 15.5. Kawasaki Heavy Industries Ltd
  • 15.6. Yaskawa Electric Corporation
  • 15.7. DENSO Wave Inc
  • 15.8. FANUC Corporation
  • 15.9. Omron Corporation
  • 15.10. Seiko Epson Corporation

16. Strategic Recommendations

17. About Us & Disclaimer